Cyclerion Therapeutics In... (CYCN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.00
0.08 (2.74%)
At close: Jan 15, 2025, 2:41 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | n/a | 297.00K | 3.32M | 2.30M | 4.51M | n/a | n/a | n/a |
Cost of Revenue | n/a | 65.00K | 472.00K | n/a | n/a | 1.53M | 1.75M | 2.17M |
Gross Profit | n/a | 232.00K | 2.85M | 2.30M | 4.51M | -1.53M | -1.75M | -2.17M |
Operating Income | -9.65M | -44.37M | -55.20M | -81.27M | -125.04M | -115.25M | -93.92M | -63.55M |
Interest Income | 358.00K | 294.00K | n/a | 588.00K | 2.03M | n/a | n/a | n/a |
Pretax Income | -12.59M | -44.08M | -51.65M | -77.80M | -123.01M | -115.25M | -93.92M | -63.55M |
Net Income | -21.02M | -43.78M | -51.66M | -72.67M | -120.98M | -115.25M | -93.92M | -63.55M |
Selling & General & Admin | 8.13M | 14.50M | 20.62M | 28.82M | 34.40M | 27.54M | 15.12M | 10.48M |
Research & Development | 1.51M | 31.49M | 37.64M | 56.41M | 95.14M | 87.72M | 78.80M | 50.90M |
Other Expenses | n/a | -1.33M | -622.00K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.65M | 44.67M | 57.63M | 85.23M | 129.54M | 115.25M | 93.92M | 61.38M |
Interest Expense | n/a | 294.00K | 16.00K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.65M | 44.67M | 57.63M | 85.23M | 129.54M | 115.25M | 93.92M | 63.55M |
Income Tax | n/a | -294.00K | 16.00K | -5.13M | -2.03M | 1.37M | n/a | n/a |
Shares Outstanding (Basic) | 2.34M | 2.17M | 1.96M | 1.52M | 1.37M | 1.37M | 1.37M | 1.37M |
Shares Outstanding (Diluted) | 2.34M | 2.17M | 1.96M | 1.52M | 1.37M | 1.37M | 1.37M | 1.37M |
EPS (Basic) | -8.99 | -20.15 | -26.4 | -47.8 | -88.37 | -84.42 | -68.8 | -46.39 |
EPS (Diluted) | -8.99 | -20.15 | -26.4 | -47.8 | -88.37 | -84.42 | -68.8 | -46.39 |
EBITDA | -12.59M | -18.18M | -55.20M | -81.27M | -122.34M | -113.72M | -92.18M | -61.38M |
Depreciation & Amortization | -2.95M | 65.00K | 472.00K | 2.30M | 2.70M | 1.53M | 1.75M | 2.17M |